[go: up one dir, main page]

WO2002040460A1 - A process for the preparation of 2-[phenothiazin-10-yl] ethyl methane sulphonate - Google Patents

A process for the preparation of 2-[phenothiazin-10-yl] ethyl methane sulphonate Download PDF

Info

Publication number
WO2002040460A1
WO2002040460A1 PCT/IN2001/000201 IN0100201W WO0240460A1 WO 2002040460 A1 WO2002040460 A1 WO 2002040460A1 IN 0100201 W IN0100201 W IN 0100201W WO 0240460 A1 WO0240460 A1 WO 0240460A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
phenothiazin
preparation
ethanol
reaction
Prior art date
Application number
PCT/IN2001/000201
Other languages
French (fr)
Inventor
Om Reddy Gaddam
Ramabhadra Sarma Mamillapalli
Chandrasekhar Batchu
Hari Charan Raju Chennamadhauni
Original Assignee
Dr. Reddy's Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Research Foundation filed Critical Dr. Reddy's Research Foundation
Priority to AU2002221030A priority Critical patent/AU2002221030A1/en
Publication of WO2002040460A1 publication Critical patent/WO2002040460A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/22[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C07D279/24[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
    • C07D279/26[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom without other substituents attached to the ring system

Definitions

  • the present invention relates to a process for the preparation of 2- [phenothiazin-10-yl]ethylmethane sulphonate of the formula (1).
  • the compound of formula (1) is an intermediate for the preparation of many pharmaceutically active compounds.
  • Ethyleneoxide used for N-alkylation of lOH-phenothiazine of the formula (2) is a low boiling solvent and will polymerise easily into polyethylene oxide, which poses handling problem in bulk quantities.
  • the reaction is carried out using moisture sensitive pyrophoric reagents such as NaNH 2 , which needs careful handling.
  • Ethylene oxide or ethylene carbonate used for N-alkylation of phenothiazine of the formula (2) can lead to radical polymerization, which poses handling problem in bulk quantities.
  • it is essential to have a commercially viable, cost effective, high yielding process for preparing the compound of formula (1).
  • the main objective of the present invention is therefore to provide an improved process for the preparation of 2-[phenothiazin-10-yl]ethylmethane sulphonate of the formula (1).
  • Another objective of the present invention is to provide an improved l o process for the preparation of 2-[phenothiazin- 10-yl] ethylmethane sulphonate of the formula (1), avoiding pyrophoric reagents, thereby making the process easy to operate in commercial scales .
  • the objective of the present invention has been achieved by employing polar aprotic solvents such as DMF, DMSO, DMAc and the like and avoiding 15 column chromatography.
  • the present invention provides a process for the preparation of 2- [phenothiazin-10-yl] ethylmethane sulphonate of the formula (1), which
  • N-alkylation lOH-phenothiazine of the formula (2) with 2-haloethanol of formula (8) wherein X represents halogen atom such as chlorine, fluorine, bromine or iodine in step (i) may be carried out in the presence of polar aprotic solvents such as DMF, DMSO, DMAc and the like in the presence of nucleophilic organic or inorganic bases such as sodium hydride, t-BuOH, and sodium methoxide.
  • the yield of the resultant, 2-[phenothiazin-10-yl]ethanol of the formula (4) is in the order of 57-66 % and purity of 99 %.
  • This compound can be used directly for the next step without purification involving column chromatography, thereby saving the time and cost.
  • the reaction of 2- [phenothiazin-10-yl]ethanol of the formula (4) with methane sulfonyl chloride may be carried out in the presence of solvent such as DCM, DCE, toluene and the like and a base such as triethylamine, tributylamine and the like.
  • the final compound namely 2- [phenothiazin-10-yl] ethylmethane sulfonate of the formula (1) is obtained in quantitative yield and purity of 99 %.
  • the invention is described in the example given below which are provided by way of illustration only and therefore should not be construed to limit the scope of the invention.
  • Step (I) 2-[Phenothiazin-10-vnethanol of the formula (4)
  • Sodium hydride (54.6 g) (60 % dispersion in oil) was taken in 2 L four necked round bottom flask and thoroughly washed with toluene (2 x 20 ml) under N 2 atmosphere with stirring.
  • DMF 200 ml was added to the washed sodium hydride, freed from oil and toluene.
  • lOH-phenothiazine (100 g) in DMF (100 ml) was added dropwise to the mixture in about 30 min.
  • Step (ii 2- rPhenothiazin-lO-yl] ethylmethane sulfonate of the formula (I) In a 2 L four necked round bottom flask fitted with a mechanical stirrer and condenser, 2-[phenothiazin-10-y ⁇ ]ethanol of the formula (4) (170 g) obtained as described in step (i) above and dichloromethane (850 ml) were added under N 2 atmosphere with stirring. Triethylamine (113.4 g, 157 ml) was added portion wise under N 2 atmosphere in about 10 min. at room temperature under stirring.
  • Methane sulfonyl chloride (107 g, ⁇ 73 ml) was added to the reaction mixture at 5-10 °C under stirring in about 30 min.
  • the reaction mass was maintained at 25-35 °C for 3 h, monitoring the reaction by TLC.
  • Demineralised water was added, followed by fresh dichloromethane and stirred for 30 min.
  • the organic layer was separated, washed with DM water (3 x 300 ml), dried over Na SO 4 and was concentrated under reduced pressure in a rotavapor to a volume of ⁇ 600 ml. Petroleum ether ( ⁇ 600 ml) was added to a cone, solution of organic layer at 10-15 °C under stirring.
  • Step (i) 2-rPhenothiazin-lO-ynethanol of the formula (4)
  • Sodium hydride (54.6 g) (60 % dispersion in oil) was taken in 2 L four necked round bottom flask and thoroughly washed with toluene (2 x 20 ml) under N 2 atmosphere with stirring.
  • DMF 200 ml was added to the washed sodium hydride, freed from oil and toluene.
  • lOH-phenothiazine (100 g) in DMF (100 ml) was added dropwise to the mixture in about 30 min. at room temperature.
  • Step (ii) 2- [Phenothiazin-10-yl] ethyl methane sulfonate of formula (1)
  • 2-[phenothiazin-10-yl]ethanol of the formula (4) (170 g) obtained as described in step (i) above and dichloromethane (850 ml) were added under N atmosphere with stirring.
  • Triethylamine 113.4 g, 157 ml was added portion wise under N 2 atmosphere in about 10 min. at room temperature under stirring.
  • Methane sulfonyl chloride (107 g, ⁇ 73 ml) was added to the reaction mixture at 5-10 °C under stirring in about 30 min.
  • the reaction mass was maintained at 25-35 °C for 3 h, monitoring the reaction by TLC.
  • Demineralised water was added, followed by fresh dichloromethane and stirred for 30 min.
  • the organic layer was separated, washed with DM water (3 x 300 ml), dried over Na SO 4 and was concentrated under reduced pressure in a rotavapor to a volume of ⁇ 600 ml. Petroleum ether ( ⁇ 600 ml) was added to a cone, solution of organic layer at 10-15 °C under stirring.
  • Sodium hydride (54.6 g) (60 % dispersion in oil) was taken in 2 L four necked round bottom flask and thoroughly washed with toluene (2 x 20 ml) under N 2 atmosphere with stirring.
  • DMF 200 ml was added to the washed sodium hydride, freed from oil and toluene.
  • lOH-phenothiazine (100 g) in DMF (100 ml) was added dropwise to the mixture in about 30 min. at room temperature.
  • the process does not require the use of expensive reagents and dry solvents, thereby making the process safe and economical.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

A process for the preparation of 2-[phenothiazin-10-yl]ethylmethane sulphonate of the formula (1) which comprises : N-alkylating the 10H-phenothiazine with 2-haloethanol in the presence of a polar aprotic solvent and a nucleophilic organic or inorganic base to get 2-[phenothiazin-10-yl]ethanol, mesylating the 2-[phenothiazin-10-yl]ethanol to the compound of formula (1) by treating with methane sulphonyl chloride in the presence of an organic base and an organic solvent and isolating the compound of formula (1) by conventional methods.

Description

A PROCESS FOR THE PREPARATION OF 2-[PHENOTHIAZIN-10- YL] ETHYL METHANE SULPHONATE
Field of the invention
The present invention relates to a process for the preparation of 2- [phenothiazin-10-yl]ethylmethane sulphonate of the formula (1).
Figure imgf000002_0001
The compound of formula (1) is an intermediate for the preparation of many pharmaceutically active compounds.
Several synthetic processes have been reported for the preparation of 2- [phenothiazin-10-yl]ethanol of the formula (4), which is an important intermediate in the preparation of 2-[phenothiazin-10-yl]ethylmethane sulphonate of formula (1).
In our international publication No. WO 98/52946, we have disclosed the compound of formula (I) and its preparation from 2-[phenothiazin-10- yl]ethanol of the formula (4).
B. Dahlbom [Swed. 129, 842 (1950), Acta. Chem. Scand. 6, 310 (1952)], described the preparation of 2-[phenothiazin-10-yl]ethanol of the formula (4) by reaction of lOH-phenothiazine of the formula (2) with ethylene oxide in presence of condensing agent such as alkali amides, PhONa, or EtCO2Li in toluene. The reaction is shown in scheme- 1 below :
Figure imgf000003_0001
Scheme - 1
This process has the following drawbacks :
• Ethyleneoxide used for N-alkylation of lOH-phenothiazine of the formula (2) is a low boiling solvent and will polymerise easily into polyethylene oxide, which poses handling problem in bulk quantities.
• The reaction is carried out using moisture sensitive pyrophoric reagents such as NaNH2, which needs careful handling.
M.G. Canquil, A Casadorall and M.E. Casadovall (Bull. Soc. Chim., France, 1566 (I960)] described the process for preparation of 2-[phenothiazin-10- yfjethanol of the formula (4) by initial fusion reaction of 10-H-phenothiazine of the formula (2) with Lithium metal, followed by reaction of 10-lithiophenic thiazine with ethyleneoxide. The reaction is shown in scheme-2 below :
Figure imgf000003_0002
Scheme-2
K. Hiroyoshi [Japan, 73, 33, 755 (1974), CA. 81 : 261835] described the process for the preparation of 2-[phenothiazin-10-yl]ethanol by fusion reaction of lOH-phenothiazine of the formula (2) with ethylene carbonate at 200 °C . The reaction is shown in scheme-3 below :
Figure imgf000004_0001
Scheme-3
O. Saburo, U. Koji [Japan Kokai, 74, 40, 675 (1974), CA 82 : 170988p (1975)] described the process for the preparation of 2-[phenothiazin-10- yfjethanol of the formula (4) by initial fusion reaction of lOH-phenothiazine of the formula (2) with KOH at 30 °C, followed by reaction of potassium salt of phenothiazine with ethylene oxide in xylene medium. The reaction is shown in scheme-4 below :
Figure imgf000004_0002
Scheme-4
The processes described in the above schemes have the following drawbacks.
• The reactions are carried out at very high temperatures ranging from 200-300 °C, which is very difficult for scale-up operations and also from safety point of view.
• At very high temperature charring of the RM was observed, affecting the yield.
• Ethylene oxide or ethylene carbonate used for N-alkylation of phenothiazine of the formula (2) can lead to radical polymerization, which poses handling problem in bulk quantities. In view of the importance of the compound of formula (1), it is essential to have a commercially viable, cost effective, high yielding process for preparing the compound of formula (1).
5 Objective of the invention
The main objective of the present invention is therefore to provide an improved process for the preparation of 2-[phenothiazin-10-yl]ethylmethane sulphonate of the formula (1).
Another objective of the present invention is to provide an improved l o process for the preparation of 2-[phenothiazin- 10-yl] ethylmethane sulphonate of the formula (1), avoiding pyrophoric reagents, thereby making the process easy to operate in commercial scales .
The objective of the present invention has been achieved by employing polar aprotic solvents such as DMF, DMSO, DMAc and the like and avoiding 15 column chromatography.
Detailed description of the Invention
Accordingly, the present invention provides a process for the preparation of 2- [phenothiazin-10-yl] ethylmethane sulphonate of the formula (1), which
20 comprises : i). N-alkylating the lOH-phenothiazine of the formula (2) with 2- haloethanol of the formula (8) where X represents halogen atom such as fluorine, chlorine, bromine or iodine in the presence of a polar aprotic solvent and a nucleophilic organic or inorganic base to get 2-[phenothiazin-10-
25 yl]ethanol of the formula (4), ii). mesylating the 2-[phenothiazin-10-yl]ethanol of the formula (4) obtained in step (i) to yield compound of formula (1) by treating with methane sulphonyl chloride in the presence of an organic base and an organic solvent and iii). isolating the compound of formula (1) by conventional methods.
The reaction is shown in scheme-5 below :
Figure imgf000006_0001
Scheme-5
The N-alkylation lOH-phenothiazine of the formula (2) with 2-haloethanol of formula (8) wherein X represents halogen atom such as chlorine, fluorine, bromine or iodine in step (i) may be carried out in the presence of polar aprotic solvents such as DMF, DMSO, DMAc and the like in the presence of nucleophilic organic or inorganic bases such as sodium hydride, t-BuOH, and sodium methoxide. The yield of the resultant, 2-[phenothiazin-10-yl]ethanol of the formula (4) is in the order of 57-66 % and purity of 99 %. This compound can be used directly for the next step without purification involving column chromatography, thereby saving the time and cost. The reaction of 2- [phenothiazin-10-yl]ethanol of the formula (4) with methane sulfonyl chloride may be carried out in the presence of solvent such as DCM, DCE, toluene and the like and a base such as triethylamine, tributylamine and the like. The final compound namely 2- [phenothiazin-10-yl] ethylmethane sulfonate of the formula (1) is obtained in quantitative yield and purity of 99 %. The invention is described in the example given below which are provided by way of illustration only and therefore should not be construed to limit the scope of the invention.
Example- 1
Step (I) 2-[Phenothiazin-10-vnethanol of the formula (4) Sodium hydride (54.6 g) (60 % dispersion in oil) was taken in 2 L four necked round bottom flask and thoroughly washed with toluene (2 x 20 ml) under N2 atmosphere with stirring. DMF (200 ml) was added to the washed sodium hydride, freed from oil and toluene. lOH-phenothiazine (100 g) in DMF (100 ml) was added dropwise to the mixture in about 30 min. 2-Chloroethanol (87.3 g) in DMF (50 ml) was added at 50-60 °C in about 1 h\ After addition, the reaction mass was maintained at room temperature for 1 h, monitoring the reaction by TLC. Methanol (100 ml) was added slowly to quench the unreacted hydride followed by toluene (2 L). The toluene layer was washed with water (3 x 1 L), decolorized with activated charcoal and concentrated on rotavapor at 50-90 °C / 150 mm till no more drops of toluene were observed. The residue was distilled in high vacuum to afford 2-phenothiazin-10- yl]ethanol of the formula (4) as light brown oil, b.p. 210 °C, (weighs about 72- 85 g, yield : 58-64%, purity 99% by HPLC). The IR, 1H-NMR data are consistent with assigned structure.
Step (ii 2- rPhenothiazin-lO-yl] ethylmethane sulfonate of the formula (I) In a 2 L four necked round bottom flask fitted with a mechanical stirrer and condenser, 2-[phenothiazin-10-yι]ethanol of the formula (4) (170 g) obtained as described in step (i) above and dichloromethane (850 ml) were added under N2 atmosphere with stirring. Triethylamine (113.4 g, 157 ml) was added portion wise under N2 atmosphere in about 10 min. at room temperature under stirring. Methane sulfonyl chloride (107 g, ~ 73 ml) was added to the reaction mixture at 5-10 °C under stirring in about 30 min. The reaction mass was maintained at 25-35 °C for 3 h, monitoring the reaction by TLC. Demineralised water was added, followed by fresh dichloromethane and stirred for 30 min. The organic layer was separated, washed with DM water (3 x 300 ml), dried over Na SO4 and was concentrated under reduced pressure in a rotavapor to a volume of ~ 600 ml. Petroleum ether (~ 600 ml) was added to a cone, solution of organic layer at 10-15 °C under stirring. The precipitated solid was filtered, dried in hot air oven at 45 °C to yield 2-[phenothiazin-10- yl)ethyl methane sulfonate of the formula (1), m.p. 113-115°C (weighs about 222 g, Yield : 95%, Purity 99% by HPLC). The IR, 1H NMR data are consistent with assigned structure.
Example 2
Step (i) : 2-rPhenothiazin-lO-ynethanol of the formula (4) Sodium hydride (54.6 g) (60 % dispersion in oil) was taken in 2 L four necked round bottom flask and thoroughly washed with toluene (2 x 20 ml) under N2 atmosphere with stirring. DMF (200 ml) was added to the washed sodium hydride, freed from oil and toluene. lOH-phenothiazine (100 g) in DMF (100 ml) was added dropwise to the mixture in about 30 min. at room temperature. 2-Bromoethanol (137 g) in DMF (50 ml) was added dropwise at room temperature in about 4 h under N2 atmosphere with stirring. After addition, the reaction mass was maintained at room temperature for 1 h, monitoring the reaction by TLC. Methanol (100 ml) was added slowly to quench the unreacted hydride followed by toluene (2 L). The toluene layer was washed with water (3 x 1 L), decolorized with activated charcoal and concentrated on rotavapor at 50-90 °C / 150 mm till no more drops of toluene were observed. The residue was distilled in high vacuum to afford 2-phenothiazin-10- yijethanol of the formula (4) as light brown oil, b.p. 210 °C (weighs about 75 g, yield 60%, purity 99% by HPLC). The IR, 1H NMR data are consistent with the assigned structure.
Step (ii) 2- [Phenothiazin-10-yl] ethyl methane sulfonate of formula (1) In a 2 L four necked round bottom flask fitted with a mechanical stirrer and condenser, 2-[phenothiazin-10-yl]ethanol of the formula (4) (170 g) obtained as described in step (i) above and dichloromethane (850 ml) were added under N atmosphere with stirring. Triethylamine (113.4 g, 157 ml) was added portion wise under N2 atmosphere in about 10 min. at room temperature under stirring. Methane sulfonyl chloride (107 g, ~ 73 ml) was added to the reaction mixture at 5-10 °C under stirring in about 30 min. The reaction mass was maintained at 25-35 °C for 3 h, monitoring the reaction by TLC. Demineralised water was added, followed by fresh dichloromethane and stirred for 30 min. The organic layer was separated, washed with DM water (3 x 300 ml), dried over Na SO4 and was concentrated under reduced pressure in a rotavapor to a volume of ~ 600 ml. Petroleum ether (~ 600 ml) was added to a cone, solution of organic layer at 10-15 °C under stirring. The precipitated solid was filtered, dried in hot air oven at 45 °C to yield 2-[phenothiazin-10- yl)ethyl methane sulfonate of the formula (1), .p. 113-115°C (weighs about 222 g, Yield : 95%, Purity 99% by HPLC). The IR, 1H NMR data are consistent with assigned structure.
Example 3
Step (i) 2- [Phenothiazin-10-yl] ethanol of the formula (4) Sodium hydride (54.6 g) (60 % dispersion in oil) was taken in 2 L four necked round bottom flask and thoroughly washed with toluene (2 x 20 ml) under N2 atmosphere with stirring. DMF (200 ml) was added to the washed sodium hydride, freed from oil and toluene. lOH-phenothiazine (100 g) in DMF (100 ml) was added dropwise to the mixture in about 30 min. at room temperature. 2-Iodoethanol (171 g, ~ 78 ml) in DMF (50 ml) was added dropwise at room temperature in about 15 h under stirring N2 atmosphere. After addition, the reaction mass was maintained at room temperature for 1 h, monitoring the reaction by TLC. Methanol (100 ml) was added slowly to quench the unreacted hydride followed by toluene (2 L). The toluene layer was washed with water (3 x 1 L), decolorized with activated charcoal and concentrated on rotavapor at 50-90 °C / 150 mm till no more drops of toluene were observed. The residue was distilled in high vacuum to afford the 2-[phenothiazin-10- yljethanol of the formula (4) as light brown oil, b.p. 210 °C, (weighs about 70 g, yield 56 %, purity 99 % by HPLC). The IR, 1H NMR data are consistent with the assigned structure.
Step (ii) 2- [Phenothiazin-10-yl] ethylmethane sulfonate of the formula (1)
In a 2 L four necked round bottom flask fitted with a mechanical stirrer and condenser, 2-[phenothiazin-10-yl]ethanol of the formula (4) (170 g) obtained as described in step (i) above and dichloromethane (850 ml) were added under N2 atmosphere with stirring. Triethylamine (113.4 g, 157 ml) was added portion wise under N2 atmosphere in about 10 min. at room temperature under stirring. Methane sulfonyl chloride (107 g, ~ 73 ml) was added to the reaction mixture at 5-10 °C under stirring in about 30 min. The reaction mass was maintained at 25-35 °C for 3 h, monitoring the reaction by TLC. Demineralised water was added, followed by fresh dichloromethane and stirred for 30 min. The organic layer was separated, washed with DM water (3 x 300 ml), dried over Na2SO and was concentrated under reduced pressure in a rotavapor to a volume of ~ 600 ml. Petroleum ether (~ 600 ml) was added to a cone, solution of organic layer at 10-15 °C under stirring. The precipitated solid was filtered, dried in hot air oven at 45 °C to yield 2-[phenothiazin-10- yl)ethyl methane sulfonate of the formula (1), m.p. 113-115°C (weighs about 222 g, Yield : 95%, Purity 99% by HPLC). The IR, 1H NMR data are consistent with assigned structure.
Advantages of the Invention • The process does not require the use of expensive reagents and dry solvents, thereby making the process safe and economical.
• The purification by column chromatography is totally avoided resulting in further economy of the process.
• The time required for the completion of the reaction is reduced drastically, the overall yield and purity of the product is enhanced thereby making the process commercially economical.
• The process is commercially viable and can be employed for the easy and quick preparation of the compounds of formula (1).

Claims

claims :
1. A process for the preparation of 2- [phenothiazin-10-yl] ethylmethane sulphonate of the formula (1)
Figure imgf000012_0001
which comprises : i). N-alkylating the lOH-phenothiazine of the formula (2)
Figure imgf000012_0002
with 2-haloethanbl of the formula (8) χ^^OH (8) where X represents halogen atom in the presence of a polar aprotic solvent and a nucleophilic organic or inorganic base to get 2-[phenothiazin-10-yl]ethanol of the formula (4),
Figure imgf000012_0003
ii). mesylating the 2- [phenothiazin-10-yl] ethanol of the formula (4) obtained in step (i) to yield compound of formula (1) by treating with methane sulphonyl chloride in the presence of an organic base and an organic solvent and iii). isolating the compound of formula (1) by conventional methods.
2. The process as claimed in claim 1, wherein the N-alkylation in step (i) is carried out in the presence of polar aprotic solvents selected from DMF,
DMSO or DMAc.
3. The process as claimed in claims 1 and 2, wherein the nucleophilic organic or inorganic base used in step (i) is selected from BuOK, sodium methoxide or sodium hydride.
4. The process as claimed in claims 1 to 3, wherein the mesylation in step (ii)is carried out in the presence of solvent selected from DCM, toluene or dichloroethane.
5. The process as claimed in claims 1 to 4, wherein the base used in step (ii) is selected from triethylamine or tributylamine.
6. A process for the preparation of 2- [phenothiazin-10-yl] ethylmethane sulphonate of the formula (1) substantially as herein described with reference to the examples.
PCT/IN2001/000201 2000-11-17 2001-11-15 A process for the preparation of 2-[phenothiazin-10-yl] ethyl methane sulphonate WO2002040460A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002221030A AU2002221030A1 (en) 2000-11-17 2001-11-15 A process for the preparation of 2-(phenothiazin-10-yl) ethyl methane sulphonate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN979MA2000 2000-11-17
IN979/MAS/2000 2000-11-17

Publications (1)

Publication Number Publication Date
WO2002040460A1 true WO2002040460A1 (en) 2002-05-23

Family

ID=11097192

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2001/000201 WO2002040460A1 (en) 2000-11-17 2001-11-15 A process for the preparation of 2-[phenothiazin-10-yl] ethyl methane sulphonate

Country Status (2)

Country Link
AU (1) AU2002221030A1 (en)
WO (1) WO2002040460A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012066048A1 (en) * 2010-11-16 2012-05-24 Solvay Sa Rechargeable metal or metal-ion cell

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998052946A1 (en) * 1997-12-02 1998-11-26 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998052946A1 (en) * 1997-12-02 1998-11-26 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
G. BIDAN: "N-(hydroxyalkyl)pyrroles: precursors for the synthesis of polypyrroles bearing active centres", TETRAHEDRON LETTERS., vol. 26, no. 6, 1985, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM., NL, pages 735 - 736, XP002190141, ISSN: 0040-4039 *
J. J. D'AMICO ET AL: "Derivatives of 3-(2-hydroxyethyl)-2-benzothiazolinone and related compounds", JOURNAL OF HETEROCYCLIC CHEMISTRY., vol. 25, 1988, HETEROCORPORATION. PROVO., US, pages 1601 - 1605, XP002190140, ISSN: 0022-152X *
J.J. D'AMICO ET AL: "Carbamates, thiolcarbamates, dithiocarbamates and thiocarbamates derived from 2-benzothiazolinone and benzoxazolinone", JOURNAL OF HETEROCYCLIC CHEMISTRY., vol. 26, 1989, HETEROCORPORATION. PROVO., US, pages 655 - 660, XP002190142, ISSN: 0022-152X *
TIERNEY M.T. ET AL: "Synthesis and characterization of fluorenone-, anthraquinone-, and phenothiazine-labeled oligodeoxynucleotides: 5'-probes for DNA redox chemistry", JOURNAL OF ORGANIC CHEMISTRY., vol. 65, no. 17, 25 August 2000 (2000-08-25), AMERICAN CHEMICAL SOCIETY. EASTON., US, pages 5355 - 5359, XP002190139, ISSN: 0022-3263 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012066048A1 (en) * 2010-11-16 2012-05-24 Solvay Sa Rechargeable metal or metal-ion cell
US9203080B2 (en) 2010-11-16 2015-12-01 Solvay Sa Rechargeable metal or metal-ion cell

Also Published As

Publication number Publication date
AU2002221030A1 (en) 2002-05-27

Similar Documents

Publication Publication Date Title
SU620206A3 (en) Method of obtaining oxime derivatives or salts thereof
KR101777474B1 (en) A method for preparing 1,3-prop-1-ene sultone
KR0176010B1 (en) Process for producing 1-amino-1,2,3-triazole
WO2002040460A1 (en) A process for the preparation of 2-[phenothiazin-10-yl] ethyl methane sulphonate
US20130184490A1 (en) Process to prepare s-2-hydroxy-3-methoxy-3,3-diphenyl propionic acid
US10723745B2 (en) Isosulfan blue, its crystalline form and process for preparation thereof
CN107540655B (en) A new method for preparing S-(perfluoroalkyl)-dibenzothiophene triflate
CN110698352B (en) A kind of synthetic method of 3-bromo-5-aminocatechol dimethyl ether
US7109353B2 (en) Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCl
CA2412543C (en) Process for the preparation of quinoline derivatives
CA2485428A1 (en) A process for the preparation of modafinil
WO2002034733A1 (en) An improved process for the preparation of 2-[phenoxazin-10-yl]ethylmethane sulphonate
CN115286491A (en) A kind of preparation method of 2-[2-(6-bromohexyloxy)ethoxymethyl]-1,3-dichlorobenzene
CN114315866B (en) Synthesis method of levamisole hydrochloride
CN111377991B (en) Preparation method of loteprednol etabonate
CN114315575A (en) Preparation method and application of photoinitiator intermediate
WO2002020498A2 (en) An improved process for the preparation of 3,4-dihydro-1,4-benzothiazine
CN111039838A (en) Preparation method of 3-acetylmercapto-2-methylpropanoic acid
JP4157361B2 (en) Method for producing 9-spirofluorene compound
US6855845B2 (en) Process for the preparing bromoisophithalic acid compound
CN110194774B (en) Preparation method of 5, 6-dihydro-6- (2-naphthyl) imidazo [2,1-b ] thiazole oxalate
CN112457272B (en) Preparation method of (3-methoxy-1, 2, 4-thiadiazole-5-amino) phenyl formate
RU2167162C1 (en) Method of synthesis of benzylpenicillin diethylaminoethyl ester hydroiodide
WO2003024944A1 (en) An improved process for the preparation of bicyclic antidiabetic compounds
US20120309973A1 (en) Preparation of 2-(4-bromophenyl)-2-methylpropanoic acid

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP